Blood Product Payment Rates Should Be Higher, APC Panel Agrees
This article was originally published in The Gray Sheet
Executive Summary
Maintaining a safe and adequate blood supply requires sufficient reimbursement for blood and blood products, according to CMS' Ambulatory Payment Classification advisory panel